Chris Edward
About Chris Edward
Chris Edward serves as the FP&A Director for the ACE region at Kite Pharma, where he has worked since 2020. He has a diverse background in finance, having held various positions at notable companies including Gilead Sciences, SABMiller, and KPMG.
Current Role at Kite Pharma
Chris Edward serves as the FP&A Director for the ACE region at Kite Pharma, a position he has held since 2020. In this role, he is responsible for financial planning and analysis, contributing to the strategic financial management of the organization. His tenure at Kite Pharma has spanned four years, during which he has focused on enhancing financial processes and supporting business objectives.
Previous Experience in Finance
Prior to his current role, Chris Edward held various positions in finance across multiple organizations. He worked at Gilead Sciences as Associate Director Finance for the UK & Ireland from 2018 to 2020. Before that, he was involved in Corporate Finance Advisory at CV Capital LLP in London for a year in 2014. His experience also includes roles at SABMiller and Anheuser-Busch InBev, where he focused on financial planning and operational integration.
Educational Background
Chris Edward studied at the University of Johannesburg, where he earned a Bachelor of Commerce with Honours in Accounting. He also completed his Chartered Accountant qualification between 2007 and 2009. Additionally, he participated in executive education at Kellogg, further enhancing his expertise in finance and management.
Career Progression
Chris Edward's career in finance began in South Africa, where he worked as an Auditor at KPMG from 2007 to 2010. He then moved to the UK, where he continued his career at KPMG UK in Transaction Advisory Services for two years. His diverse experience includes roles in business development finance at ESPN and various finance positions at Gilead Sciences, culminating in his current directorial role at Kite Pharma.